• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫炎症标志物在预测 COVID-19 患者临床结局中的意义。

Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients.

机构信息

Department of Pathology, All India Institute of Medical Sciences, Patna, Bihar, India.

出版信息

Indian J Pathol Microbiol. 2023 Jan-Mar;66(1):111-117. doi: 10.4103/ijpm.ijpm_658_21.

DOI:10.4103/ijpm.ijpm_658_21
PMID:36656221
Abstract

BACKGROUND

The epidemic of coronavirus disease 2019 (COVID-19) has been rapidly spreading on a global scale affecting many countries and territories. There is rapid onset of generalized inflammation resulting in acute respiratory distress syndrome. We, thus, aimed to explore the potential of immune-inflammatory parameters in predicting the severity of COVID-19.

MATERIALS AND METHODS

Age, neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), Lactate Dehydrogenase (LDH), C-reaction protein (CRP), and procalcitonin (PCT) of 611 patients with laboratory-confirmed COVID-19 were investigated and compared. Patients were divided on the basis of severity and survival into two groups. Data were expressed as mean or median values and percentages. The receiver operating characteristic curve was applied to determine the optimal cut-off values of these biomarkers.

RESULTS

The median age was 50 years and the male to female ratio was 3.7:1. The mean NLR, LMR, PLR, LDH, CRP, and Procalcitonin for the non-severe group were 4.16, 10.8, 133.7, 666.1, 49.9, and 0.15, respectively. In the severe group mean values of the above-mentioned immune-inflammatory markers were 17.8, 4.69, 268.2, 1277, 158.6, and 3.05, respectively. Elevated levels were significantly associated with disease severity. In ROC curve analysis, NLR had the largest area under the curve at 0.923 with the highest specificity (0.83) and sensitivity (0.88).

CONCLUSION

This study shows that NLR, PLR, LDH, CRP, and Procalcitonin may be a rapid, widely available, useful predictive factor for determining the severity of COVID-19 patients.

摘要

背景

2019 年冠状病毒病(COVID-19)疫情在全球范围内迅速蔓延,影响了许多国家和地区。其具有迅速发生的全身性炎症,导致急性呼吸窘迫综合征。因此,我们旨在探索免疫炎症参数在预测 COVID-19 严重程度方面的潜力。

材料和方法

对 611 例经实验室确诊的 COVID-19 患者的年龄、中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)、血小板与淋巴细胞比值(PLR)、乳酸脱氢酶(LDH)、C 反应蛋白(CRP)和降钙素原(PCT)进行了研究和比较。根据严重程度和存活情况将患者分为两组。数据表示为平均值或中位数和百分比。应用受试者工作特征曲线确定这些生物标志物的最佳截断值。

结果

中位年龄为 50 岁,男女比例为 3.7:1。非重症组的平均 NLR、LMR、PLR、LDH、CRP 和 Procalcitonin 分别为 4.16、10.8、133.7、666.1、49.9 和 0.15。在重症组中,上述免疫炎症标志物的平均值分别为 17.8、4.69、268.2、1277、158.6 和 3.05。升高的水平与疾病严重程度显著相关。在 ROC 曲线分析中,NLR 的曲线下面积最大,为 0.923,特异性(0.83)和敏感性(0.88)最高。

结论

本研究表明,NLR、PLR、LDH、CRP 和 Procalcitonin 可能是一种快速、广泛可用、有用的预测因子,可用于确定 COVID-19 患者的严重程度。

相似文献

1
Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients.免疫炎症标志物在预测 COVID-19 患者临床结局中的意义。
Indian J Pathol Microbiol. 2023 Jan-Mar;66(1):111-117. doi: 10.4103/ijpm.ijpm_658_21.
2
Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis.194 例脓毒症患者 C 反应蛋白、降钙素原和免疫细胞比值的研究。
BMC Emerg Med. 2021 Jul 7;21(1):81. doi: 10.1186/s12873-021-00477-5.
3
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.白细胞介素-6、降钙素原和中性粒细胞与淋巴细胞比值:潜在的免疫炎症参数,可用于识别 COVID-19 的严重和致命形式。
Cytokine. 2021 May;141:155428. doi: 10.1016/j.cyto.2021.155428. Epub 2021 Jan 15.
4
Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.术后中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及淋巴细胞与单核细胞比值对早期人工关节周围感染诊断的预测价值:一项初步研究。
J Orthop Surg Res. 2020 Nov 30;15(1):571. doi: 10.1186/s13018-020-02107-5.
5
The Diagnostic and Predictive Roles of Neutrophil-Lymphocyte Ratio for Severity of Disease in COVID-19 Patients.中性粒细胞与淋巴细胞比值对 COVID-19 患者疾病严重程度的诊断和预测作用。
Clin Lab. 2021 Dec 1;67(12). doi: 10.7754/Clin.Lab.2021.210449.
6
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
7
Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、嗜中性粒细胞与淋巴细胞比值和嗜酸性粒细胞与淋巴细胞比值在鉴别新冠肺炎患者是否合并肺炎中的作用。
Int J Clin Pract. 2021 Nov;75(11):e14781. doi: 10.1111/ijcp.14781. Epub 2021 Sep 12.
8
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Can Predict the Severity in COVID-19 Patients from Ethiopia: A Retrospective Study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值可预测埃塞俄比亚新冠肺炎患者的病情严重程度:一项回顾性研究
Int J Gen Med. 2022 Oct 7;15:7701-7708. doi: 10.2147/IJGM.S383558. eCollection 2022.
9
Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.新型冠状病毒病(COVID-19)不同严重程度的炎症和非炎症指标的差异。
Infect Genet Evol. 2020 Nov;85:104511. doi: 10.1016/j.meegid.2020.104511. Epub 2020 Aug 26.
10
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重患者院内死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.

引用本文的文献

1
Multi-Modal Machine Learning Approach for COVID-19 Detection Using Biomarkers and X-Ray Imaging.使用生物标志物和X射线成像的COVID-19多模态机器学习检测方法
Diagnostics (Basel). 2024 Dec 13;14(24):2800. doi: 10.3390/diagnostics14242800.
2
[Clinical features of children with coronavirus disease 2019 in different age groups during the epidemic of Omicron variant].[奥密克戎变异株流行期间不同年龄组儿童新型冠状病毒肺炎的临床特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jun 15;25(6):600-605. doi: 10.7499/j.issn.1008-8830.2302014.
3
Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis.
益生菌通过肠-肺轴改善COVID-19患者的症状:一项系统评价和荟萃分析。
Front Nutr. 2023 May 22;10:1179432. doi: 10.3389/fnut.2023.1179432. eCollection 2023.